N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane

C77H107N23O10 — CID 160808876

About N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane

N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane (PubChem CID 160808876) has the molecular formula C77H107N23O10 and a molecular weight of 1514.85 g/mol. Its IUPAC name is N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane.

Molecular Properties

• Compound Name: N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane
• PubChem CID: 160808876
• Molecular Formula: C77H107N23O10
• Molecular Weight: 1514.85 g/mol
• Exact Mass: 1513.86
• IUPAC Name: N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane
• SMILES: C.CC(=O)N[C@@H](CCCCN)c1nnc(-c2ccccc2)o1.CC(=O)N[C@@H](CCCCN)c1nnc(-c2ccccn2)o1.CC(=O)N[C@@H](CCCCN)c1nnc(-c2ccccn2)o1.CC(=O)N[C@@H](CCCCN)c1nnc(-c2cccnc2)o1.CC(=O)N[C@@H](CCCCN)c1nnc(C2(c3ccc(C)cc3)CC2)o1
• InChI: InChI=1S/C19H26N4O2.C15H20N4O2.3C14H19N5O2.CH4/c1-13-6-8-15(9-7-13)19(10-11-19)18-23-22-17(25-18)16(21-14(2)24)5-3-4-12-20;1-11(20)17-13(9-5-6-10-16)15-19-18-14(21-15)12-7-3-2-4-8-12;2*1-10(20)17-12(7-2-4-8-15)14-19-18-13(21-14)11-6-3-5-9-16-11;1-10(20)17-12(6-2-3-7-15)14-19-18-13(21-14)11-5-4-8-16-9-11;/h6-9,16H,3-5,10-12,20H2,1-2H3,(H,21,24);2-4,7-8,13H,5-6,9-10,16H2,1H3,(H,17,20);2*3,5-6,9,12H,2,4,7-8,15H2,1H3,(H,17,20);4-5,8-9,12H,2-3,6-7,15H2,1H3,(H,17,20);1H4/t16-;13-;3*12-;/m00000./s1
• InChIKey: SEBBFZPEZWAKCN-YASIJKSESA-N
• XLogP: 9.76
• TPSA: 508.87 Ų
• H-Bond Donors: 10
• H-Bond Acceptors: 28
• Rotatable Bonds: 36
• Heavy Atoms: 110
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	1514.85
LogP ≤ 5	9.76
H-Bond Donors ≤ 5	10
H-Bond Acceptors ≤ 10	28

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane?

The IUPAC name of N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane (CID 160808876) is N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane.

What is the SMILES notation for N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane?

The canonical SMILES for N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane is C.CC(=O)N[C@@H](CCCCN)c1nnc(-c2ccccc2)o1.CC(=O)N[C@@H](CCCCN)c1nnc(-c2ccccn2)o1.CC(=O)N[C@@H](CCCCN)c1nnc(-c2ccccn2)o1.CC(=O)N[C@@H](CCCCN)c1nnc(-c2cccnc2)o1.CC(=O)N[C@@H](CCCCN)c1nnc(C2(c3ccc(C)cc3)CC2)o1.

What is the InChIKey of N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane?

The InChIKey is SEBBFZPEZWAKCN-YASIJKSESA-N. The full InChI is InChI=1S/C19H26N4O2.C15H20N4O2.3C14H19N5O2.CH4/c1-13-6-8-15(9-7-13)19(10-11-19)18-23-22-17(25-18)16(21-14(2)24)5-3-4-12-20;1-11(20)17-13(9-5-6-10-16)15-19-18-14(21-15)12-7-3-2-4-8-12;2*1-10(20)17-12(7-2-4-8-15)14-19-18-13(21-14)11-6-3-5-9-16-11;1-10(20)17-12(6-2-3-7-15)14-19-18-13(21-14)11-5-4-8-16-9-11;/h6-9,16H,3-5,10-12,20H2,1-2H3,(H,21,24);2-4,7-8,13H,5-6,9-10,16H2,1H3,(H,17,20);2*3,5-6,9,12H,2,4,7-8,15H2,1H3,(H,17,20);4-5,8-9,12H,2-3,6-7,15H2,1H3,(H,17,20);1H4/t16-;13-;3*12-;/m00000./s1.

What are the key properties of N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane?

N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane has a molecular weight of 1514.85 g/mol, XLogP of 9.76, 36 rotatable bonds, 10 hydrogen bond donors, and 28 hydrogen bond acceptors.

Where does this data come from?

All data for N-[(1S)-5-amino-1-[5-[1-(4-methylphenyl)cyclopropyl]-1,3,4-oxadiazol-2-yl]pentyl]acetamide;N-[(1S)-5-amino-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;bis(N-[(1S)-5-amino-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide);N-[(1S)-5-amino-1-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)pentyl]acetamide;methane is sourced from PubChem (CID 160808876), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).